Genpact Limited (NYSE:G) to Issue Quarterly Dividend of $0.09

Genpact Limited (NYSE:G) declared a quarterly dividend on Thursday, October 17th, Zacks reports. Shareholders of record on Monday, December 9th will be paid a dividend of 0.085 per share by the business services provider on Wednesday, December 18th. This represents a $0.34 dividend on an annualized basis and a yield of 0.85%. The ex-dividend date of this dividend is Friday, December 6th.

NYSE G opened at $40.20 on Wednesday. The stock has a market capitalization of $7.73 billion, a price-to-earnings ratio of 25.13, a PEG ratio of 2.14 and a beta of 0.79. Genpact has a one year low of $25.48 and a one year high of $44.55. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.46 and a quick ratio of 1.46. The business’s fifty day moving average is $39.61 and its 200-day moving average is $38.93.

Genpact (NYSE:G) last issued its quarterly earnings results on Thursday, November 7th. The business services provider reported $0.56 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.04. The company had revenue of $888.80 million for the quarter, compared to the consensus estimate of $884.91 million. Genpact had a net margin of 8.84% and a return on equity of 21.42%. The firm’s quarterly revenue was up 18.8% on a year-over-year basis. During the same period in the previous year, the firm earned $0.48 EPS. Research analysts expect that Genpact will post 1.7 EPS for the current fiscal year.

G has been the topic of several research reports. Wedbush lifted their price objective on shares of Genpact from $33.00 to $45.00 and gave the stock a “neutral” rating in a research report on Thursday, August 8th. Bank of America increased their target price on shares of Genpact from $40.00 to $43.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. Cantor Fitzgerald raised their price target on shares of Genpact from $40.00 to $47.00 and gave the stock an “overweight” rating in a research note on Thursday, August 8th. ValuEngine lowered shares of Genpact from a “buy” rating to a “hold” rating in a research note on Friday, September 27th. Finally, Deutsche Bank lifted their price target on shares of Genpact from $36.00 to $44.00 and gave the stock a “hold” rating in a report on Thursday, August 8th. Six research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $40.18.

In related news, Director David Humphrey sold 12,916,004 shares of the business’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $39.87, for a total value of $514,961,079.48. Following the sale, the director now directly owns 34,907 shares in the company, valued at approximately $1,391,742.09. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 1.86% of the company’s stock.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. Its finance and accounting services include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; invoice-to-cash services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; enterprise performance management consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls.

See Also: What is the S&P/ASX 200 Index?

Dividend History for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with's FREE daily email newsletter.